Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular metabolism is the comprehensive set of biochemical reactions occurring within a cell, encompassing both anabolic pathways for biosynthesis and catabolic pathways for energy production [1, 3]. It is not a singular molecular target but rather a vast network of enzymes, transporters, and regulatory proteins that maintain cellular homeostasis [3, 14]. Pathological alterations in intracellular metabolism are characteristic of many diseases, most notably the 'Warburg effect' in cancer, where cells shift toward aerobic glycolysis to fuel rapid growth [4, 12]. Therapeutic strategies often target specific nodes within this network, such as metabolic enzymes (e.g., hexokinase, lactate dehydrogenase) or nutrient transporters, to disrupt disease-specific metabolic dependencies [4, 7]. Because metabolic pathways are fundamental to all living cells, drug development in this area must carefully balance therapeutic efficacy against the risk of damaging healthy tissues [8, 9].
Inhibition of specific metabolic enzymes, transporters, or regulatory pathways to modulate nutrient flux and energy production.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular metabolism.